These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome. Rhodus NL; Bereuter J J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy in dentistry: a review. Shilpashree HS; Sarapur S N Y State Dent J; 2013; 79(5):60-4. PubMed ID: 24245465 [TBL] [Abstract][Full Text] [Related]
8. The use of gene transfer for the protection and repair of salivary glands. Vitolo JM; Baum BJ Oral Dis; 2002 Jul; 8(4):183-91. PubMed ID: 12206399 [No Abstract] [Full Text] [Related]
9. The impact of gene therapy on dentistry: a revisiting after six years. Baum BJ; Kok M; Tran SD; Yamano S J Am Dent Assoc; 2002 Jan; 133(1):35-44. PubMed ID: 11811741 [TBL] [Abstract][Full Text] [Related]
10. Optimizing dry mouth treatment for individuals with Sjögren's syndrome. Wu AJ Rheum Dis Clin North Am; 2008 Nov; 34(4):1001-10, x. PubMed ID: 18984418 [TBL] [Abstract][Full Text] [Related]
11. Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome. Kok MR; Baum BJ; Tak PP; Pillemer SR Ann Rheum Dis; 2003 Nov; 62(11):1038-46. PubMed ID: 14583564 [TBL] [Abstract][Full Text] [Related]
12. Management of the oral features of Sjögren's syndrome. Gravenmade EJ; Vissink A Neth J Med; 1992 Apr; 40(3-4):117-24. PubMed ID: 1603201 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived cells: A potential approach for the treatment of xerostomia. Tran SD; Sumita Y; Khalili S Int J Biochem Cell Biol; 2011 Jan; 43(1):5-9. PubMed ID: 21035563 [TBL] [Abstract][Full Text] [Related]
14. Current status of gene delivery and gene therapy in lacrimal gland using viral vectors. Selvam S; Thomas PB; Hamm-Alvarez SF; Schechter JE; Stevenson D; Mircheff AK; Trousdale MD Adv Drug Deliv Rev; 2006 Nov; 58(11):1243-57. PubMed ID: 17056149 [TBL] [Abstract][Full Text] [Related]
15. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome. Lodde BM; Mineshiba F; Wang J; Cotrim AP; Afione S; Tak PP; Baum BJ Ann Rheum Dis; 2006 Feb; 65(2):195-200. PubMed ID: 15975969 [TBL] [Abstract][Full Text] [Related]
16. How to assess treatment efficacy in Sjögren's syndrome? Vissink A; Bootsma H; Kroese FG; Kallenberg CG Curr Opin Rheumatol; 2012 May; 24(3):281-9. PubMed ID: 22450393 [TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome: a challenge for dentistry. Gobetti JP; Froeschle ML Gen Dent; 1997; 45(3):268-72. PubMed ID: 9515428 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential for B-cell modulation in Sjögren's syndrome. Mariette X Rheum Dis Clin North Am; 2008 Nov; 34(4):1025-33, x. PubMed ID: 18984420 [TBL] [Abstract][Full Text] [Related]
19. Salivary gland dysfunction and xerostomia in Sjögren's syndrome. Jensen SB; Vissink A Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192 [TBL] [Abstract][Full Text] [Related]
20. Managing dry eyes and dry mouth in Sjögren's syndrome. Kassan SS Am J Manag Care; 2001 Sep; 7(14 Suppl):S444-50. PubMed ID: 11605979 [No Abstract] [Full Text] [Related] [Next] [New Search]